Pipeline
Trials
People
News
Publications
Contact
Contact
Programs
Careers
Technology
Clinical Trials
Pipeline
Publications
Contact
People
Technology
News
Button Text
April 25, 2022
AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)
February 16, 2022
AI Therapeutics Appoints Brigette Roberts, M.D., as Chief Executive Officer
January 13, 2022
AI Therapeutics Announces Initiation of a Phase II Clinical Trial of AIT-101 for Treatment of ALS
January 16, 2020
AI Therapeutics Announces that a Common LAM-002 Mechanism in Cancer and Neurodegenerative Diseases Shows Antitumor Activity in the Clinic and Hope for ALS